ABBAS KEBRIAEEZADEH

Date of Birth; 22 May 1966

Present position:

Professor

Faculty of Pharmacy

TEHRAN UNIVERSITY OF MEDICAL SCIENCES,

TEHRAN, P.O.Box 14155/6451; I.R.IRANE mail: kebriaee@sina.tums.ac.ir

kebriaee@osvahpharma.com

Qualifications;

Pharm.D.

UNIVERSITY OF TEHRAN 1991

Ph.D

Department of pharmacology, Shahid Beheshti University of Medical Sciences (1996).

Scholarships and awards

1-International Brain Research organization (IBRO) Postdoctoral workshop (6-25 April 1994) Chinese university of Hong Kong

2- Short course; Adapting Disease Specific Quality of Life Measurement for Utility Measurement, 3 November 2002 at the ISPOR Fifth Annual European congress ,

Rotterdam, The Netherlands, 3-5 November2002.

3- Short course; Pharmacoeconomic Evaluation: Methods and Applications for Decision Making, 2 November 2002 at the ISPOR Fifth Annual European congress ,

Rotterdam, The Netherlands, 3-5 November2002.

Position Held

2014- 2017 chairman of Board of Director, Social Security Organization, Iran

2007 - Now Professor of pharmacology , Department of Toxicology & pharmacology , the head of department of pharmacoeconomics and pharmaceutical management, faculty of pharmacy, TEHRAN UNIVERSITY OF MEDICAL SCIENCES , Tehran, Iran.

2004- Now The head of pharmaceutical sciences research network, ministry of health, IRAN

2015 – Now president of pharmacoeconomics and pharmaceutical research center, Tehran University of Medical Sciences, Tehran, Iran.

2014- 2015 president, Alhavi pharmaceutical co., Tehran, Iran

2012-2014 Director General of Alhavi pharmaceutical co., Tehran, Iran

2005 – 2012 Director general, Osvah pharmaceutical Co., Tehran, Iran

2004 – 2007 Manager of pharmaceutical incubator center, Tehran University of Medical Sciences.

2002 - 2007 Associate professor in pharmacology , Department of Toxicology & pharmacology , faculty of pharmacy, TEHRAN UNIVERSITY OF MEDICAL SCIENCES.

1999 – 2003 Director General , Pharmaceutical Division of MOH.

1996 - 2002- Assistant professor in pharmacology,Department of Toxicol & pharmacol , TEHRAN UNIVERSITY OF MEDICAL SCIENCES,and Deputy of education, faculty of pharmacy.

1991-1996 Ph.D. student in department of Pharmacology and lecturer in faculty of pharmacy, Tehran University of Medical Sciences, Tehran, IRAN

Pharmacy student in Faculty of Pharmacy, UNIVERSITY OF THERAN,I.R.IRAN.

Papers

1.Shafiee A.,Cheraghali A.M.,Kebriyaeezadeh A.(1988) sepectrophotometry and gas chromatography of mustards; Med. J. I.R. IRAN , vol. 2, Nos 3, 213-218.

2. Abdollahi M., Jafari A., Jalali N., Balali -Mood M., Kebriyaeezadeh A., Nikfar S., (1995) A new approch to the effficacy of oximes in the management of acute organophosphate poisoning; Iranian J. Med. Sci vol. 20 , nos 3-4, 105-109.

3. Abdollahi M., Balali-Mood M., akhgari M., Jannat B., kebriyaeezadeh A. Nikfar S.,(1996) A survey of cholinestrase activity in healty and organophosphate expoused populations. Iranian J. Med .Sci. vol. 21, nos 1-2, 63-68.

4. kebriyaeezadeh A., (1992) Angiotensin and angiotensin converting enzyme inhibitors (article reveiw). Razi,vol9,6-17. (persian Language) .

5. Kebriyaeezadeh A. (1994) The nasal decongestants (article review)Razi,vol.12,11-16,(persian Language).

6. kebriyaeezadeh A., (1994) Pharmacokinetic of valproic acid. Razi,vol9,10-15.

7. Kebriyaeezadeh A. (1995) Species differences in response to drugs. Razi vol 9,21-26 (Persian Language).

8. Kebriyaeezadeh A., Sharifzadeh M., Soltaninejad K., (1998) Investigation of PTU-induced hypothyroidism on PTZ induced kindling parameters in chronic lead intoxicated rats. Med.J. of I.R.IRAN 12 ( 2): 141-146.

9. Sharifzadeh M.,Abdollahi M.,Kebriyaeezadeh A., Dehpour A.R., Mohammad M., (1997)Altrations of physostigmine-induced yawning by chronic lithium in rats

10. Kebriyaeezadeh A.,Abdollahi M.,Sharifzadeh M.,Baradaran M.,(1997) Lead levels in the inhabitants of tehran city districts. Pejouhandeh vol.2,no.2,67-72.

11.Sh.Nickfar,M.Abdollahi,A.Kebriyaeezadeh,M.chitsaz;(1997)Effect of granisetron on morphin induced analgesia in mice by formalin test.Gen Pharmacol vol31,no1,55-58.

12. Kebriyaeezadeh A. Valae, M., and A.Zarghi; (1998) Determination of valporic acid in human plasma by gas chromatography. Pharm Phamacol Commun 4: 525-527.

13. G. Behzadian-nejad, A. Rezaee, A. Kebriyaeezadeh, and R. Ahmadkaniha; (1998) High performance liquid chromatographic determination of trimetoprime in mouse liver, Pharm Pharmacol Commun 4: 439-441.

14. A. kebriyaezadeh A., Mazaheri F., Abdollahi M., The protective effects of SP antagonists on ophthalmic effects of Nitrogen mustard; Kosar of Med. Journal, spring, 1999; PP: 49-54.

15. Kebriyaeezadeh A. , A. Zarghi, R. Ahmadkhaniha, A. Khoddam and A.J. Ebrahimian,. (2000), Simultaneous High performance liquid Chromatographic determination of sulphamethoxazole and trimethoprim in the plasma of man,Pharm.Pharmacol. Comman.,vol.4,439-441.

16. Kebriyaeezadeh A. , Parvar Gh. Parinegad S., Taghipour M. (2000) Statistical evaluation of drug uses in IRAN, in 1378 (1999 – 2000). Razi, No. 6; 55-61.

17. Ostad S.N.,Kebriaeezadeh A.,Zarekamali R., Abdollahi M., Marzban , Akhgari (2001) The protective effect of indomethacine on HP-induced ocular damage in the eye, Med J.I.R. of Iran 14(4);385-391.

18. Zarghi A., Kebriaeezadeh A., Ahmadkaniha A.R., (2001) Rapid high performance of liquid chromatographic method for determination of doxycycline in human plsma,Boll. Chim. farmac. 140(2);112-114.

19. Kebriaeezadeh A., Masiha Akbar R., Soltaninejad K., (2001) Alteration of PTZ- induced kindling parameters by prenatal lead exposure ia rats.Daru;9(3-4);24-27.

20. Ghane T., Kebriaeezadeh A., Ostad S.N., Dehpour A.R.(2001) The effect of lead acetate on the NO system in the rat hypocampal cells an invitro study. Acta Medica Iranica;9(1);57-62.

21.Kebriaeezadeh A.,Inanlo H.R.,(2001) critsfield jakob disease;Razi,12,39-43.

22. Kebriaeezadeh A.,Habibi F.,Samiee M.,Parvar G.R.;(2001) Statistical reports on drug uses in Iran in period of april2000-april2001,( 2001);Razi,9;46-55.

23. Kebriaeezadeh A. Statistical reports on drug uses of central nervous agents in duration of april2000-april2001 in Iran;Iranian journal of neurology,1(2-3);1-2.

24.Khalaj A.,Abdollahi M.,Kebriaeezadeh A.,Adibpour N.,Pandi Z.,Rasoulamini S.,(2002) The antiniciceptive and anti-inflammatory activities and lack of ulcerogenicity of a benzodioxine-4-one and its analog benzoxazine as cyclic acetal like derivatives of salicylic acid and salycylamide in mice and rats,Indian journal of pharmacology,34

25. Kebriaeezadeh A.,Mirahmadi N.,(2002) The regulations of drug distribution in France,Italy and Germany ;Razi,147;55-69.

26. Kebriaeezadeh A.,Inanlou H.R.; (2002) The cardiotoxic and neurotoxic effect of first generation of antihistamines; Razi,vol4,141-145.

27. Zarghi A.,Kebriaeezadeh A.,Ahmadkhaniha R.,Rastkari N.,(2001) Selective liquid chromatographic method for determination of fluoxetine in plasma, J. AOAC intern. Vol84(6),1-3.

28. Kebriaeezadeh A.,Abdollahi-Asl A., Razavi S.A.M., (2002) The Economical Sitiation of Pharmacies in Iran; Razi 11;62-70.

29. Akhgari M., Abdollahi M., Kebriaeezadeh A., Hosseni R., Sabzevari O.,(2003) Biochemical Evidence for Free Radical-Induced Lipid Peroxidation as a Mechanism for Subchronic Toxicity of Malathion in Blood and Liver of Rats. Human & Experimental Toxicology; 22:205 – 211.

30. Kazemifard A.G., Moore D.E., Mohammadi A., Kebriaeezadeh A., (2003) Capillary Gas Chromatography Determination of Benzaldehyde Arising from Benzyl Alcohol Used as Preservative in Injectable Formulations. Journal of Pharmaceutical and Biomedical Analysis; 31: 685 – 691.

31. Soltaninejad K.,Kebriaeezadeh A., Minaee B.,Ostad S.N., Hosseini R., Azizi E., Abdollahi M.,(2003) Biochemical and ultrastructural evidences for toxicity of lead through free radicals in rat brain. Human & Experimental Toxicology 22:417-423.

32. Miri R.,Javidnia K., Kebriaie-zadeh A., Niknahad H., Shaygani N., Semnanian S., Shafiee A.,(2003) Synthesis and evaluation of pharmacological activities 3,5-dialkyl 1,4-dihydro – 2,6- dimethyl-4-nitroimidazole 3,5-pyridine dicarboxylates. Arch.Pharm.Pharm.Med.Chem;336:422-428.

33- Abbas Kebriaee-zadeh; Overview of National Drug Policy of Iran, Iranian Journal of Pharmaceutical Research (2003) I-II

34 . A.Almasirad, Sayyed A. Tabatabai, M. Faizi, A. Kebriaeezadeh, N. Mehrabi, A. Dalvandi, A. Shafiee (2004); Synthesis and Anticonvulsant Activity of New 2-Substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-Triazoles; Bioorganic & medical chemistry letter 14: 6057-6059.

35. Sh. Rezazadeh, A. Kebryaeezadeh, M. Pirali-Hamedani, A. Shafiee, S. Gharuni Isfahani;( 2005) Anti-inflammatory and analgesic activity of methanolic extracts of aerial parts of Stachys schtschegleevii Sosn. and Stachys balansae Boiss. & Kotschy ex Boiss in rats; Daru 13(4), 165-169.

36. S. Karkheiran, A. Kebriaeezadeh, H. Pakdaman, K. Soltaninejad (2005); Valeriana Officinalis total extract as adjunctive therapy in patients withrefractory symptomatic generalized epilepsy; Iranian Journal of Neurology 3(9); 51-65.

37. S. Nikfar, A. Kebriaeezadeh, R. Majdzadeh, M. Abdollahi (2005); Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran; BMC International and Human Rights; 5: 1-15.

38. V. Ziaee, E.Akbari Hamed, A.Hoshmand, H. Amini, A. Kebriaeezadeh, K. Saman (2005); Side effects of dextrometorphan abuse, a case series; Addictive Bahaviors, 30, 1607-1613.

39. S. Emami, A. Kebriaeezadeh, M. J. Zamani, A. Shafiee;(2006): azolylchromans as a novel scaffold for anticonvulsant activity; Bioorganic & medical chemistry letter16; 1803-1806.

40. S.N.Ostad, M. Sharifzadeh, E. Azizi, A. Kebriaeezadeh; (2006) Lead exposure impairs NMDA agonist- induced NO production in pyramidal hippocampal cells; DARU 14(1); 44-50.

41. N.Hashemi, A. Mohammadirad, Z. Bayrami, R. Khorasani, S. Vosough, A. Aliahmad, Sh. Nikfar, M. Sharifzadeh, A. Kebriaeezadeh, and M. abdollahi (2006); Restoration of morphin- induced alteration in rat submandibular gland function by N-methyl-D-aspartate agonist ,Acta Biologica Hungarica; 57(3); 283-294.

42. E.Souri,H.Jalalizadeh, A. Kebriaee zadeh, M. Shekarchi, and A. Dalvandi (2006); Validated HPLC method for determination of carboxylic acid metabolite of clopidogrel in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr 20: 1309- 1314.

43. E. Souri, H. Jalalizadeh, A. Kebriaee zadeh, and B. Zadehvakili, (2007); HPLC analysis of orlistat and its application to drug quality control studies. Chem. Pharm. Bull.55(2),

44.M.Hadipour Dehshal , A.H. Hooghooghi , A. Kebriaeezadeh, M. Kheirabadi, Sh. Kazemi, A. Nasseh, A. Shariftabrizi, P. Pasalar (2007); Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients; Med Sci. Monit, 13(5):CR235-239.

45. Ali Almasirad,Nasim Vousooghi, Sayyed Abbas Tabatabai, Abbas Kebriaeezadeh and Abbas Shafiee ( 2007); Synthesis, Anticonvulsant and Muscle relaxant activities of Substituted 1,3-,4- oxadiazole, 1,3, 4- thiadiazole and 1,2,4- triazole; Acta Chim Slov,54, 317 – 324.

46. Reza Ahmadkhanihaa, Noushin Rastkarib, Farzad Kobarfardc,

Hossein Pakdamand, Omid Ahmadkhanihae, Abbas Kebriaeezadehf,; (2008)

An Improved GC Method for Rapid Analysis of Valproic Acid

in Human Plasma without Derivatization; IJPS; October 2008; 37-41.

47. Abbas Kebriaeezadeh, Saeed Emami,Mohsen Ebrahimi ,

Mohammad Sharifzadeha, Reza Khorasani, Abbas Shafiee;(2008); Anticonvulsant and antiepileptogenic effects of azolylchromanones on lithiumepilocarpine induced seizures and pentylenetetrazole-kindling model of epilepsy; Biomedicine et Pharmacotherapy

; Vol 62/4(2008) pp 208-211.

48. Reza Afshar, Suzan Sanavi, Abbas Kebryaeezadeh, Mohsen Naiebpoor, Mahboob Lesanpezeshki, Mohammad-Reza Khatami, Effat Razeghi;(2008)Hemoglobin and Hematocrit Rise in End-Stage Renal Disease (ESRD) with PDpoetin: Results of a Phase ?, Multicenter Clinical Trial; Iranian journal of pathology;3;157-60.

49- H.Vatandoos,A.Khazani, J. Rafinejad, M. Khobde, A Kebriai Zadeh, MR Abtahi;(2008) comparative efficacy of neem and dimethylphthalate (DMP) againt malaria vector, Anopheles stephensi(dip-tera;culicidae); Asian pac J trop med,1(3), 1-6.

50- Hussein Rayatzadeh a, Mohsen Nouri a,b, Mehdi Ghasemi a, Abbas

Kebriaeezadeh , Shahram Ejtemaei Mehr a, Ahmad Reza Dehpour;

(2009)Effect of metal chelating agents on pentylenetetrazoleinduced

seizure threshold in cholestatic mice; Seizure . 18; 51-56.

51- Seyed Vahid Shetab Boushehri¹, Maryam Tamimi², and Abbas Kebriaeezadeh ², Quantitative determination of 3,4- methylenedioxymethamphetamine by thin- layer chromatography in ecstasy illicit Pills in Tehran , Toxicology Mechanisms and Methods,2009,19(9):565-569

52- SH.Rezazadeh¹,J.Zaringhalam^2*,H.Manaheji²,A. Kebryaeezadeh³- Anti-inflammatory and anti-hyperalgesic activities of Stachys athorecalyx extracts on CFA- induced inflammation- Journal of Medicinal Plants Research Vol.3(5),pp. 368-376,May,2009

53- Abbas Shafiee, Ardeshir Rineh, Abbas Kebriaeezadeh, Alireza Foroumadi, Vahid Sheibani and Mohammad Reza Afarinesh^{; (2009)}Synthesis and anticonvulsant activity of 4-(2-phenoxyphenyl)semicarbazones ;Medicinal chemistry research;18(9);758-769.

54- S.J. Hosseinimehr, D. Beiki, A. Kebriaeezadeh, A. Khalaj, M. Pirali Hamedani, S. Akhlaghpoor, H. Esmaeili, A.R. Barazesh,Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice.Iran. J. Radiat. Res., 2009; 7 (2): 91-96

.

55- MASSOUD AMANLOU*, MOHADESEH ZAREI-GHOBADI,MOHAMMAD KAZEM ROFOUEI,SHAHROOZ SAREMI and ABBAS KEBRIAEEZADEH , Extractive Spectrophotometric method for Determination of Pioglitazone Hydrochloride in Raw Material and Tablets Using Ion- Pair Formation- E-Journal of Chemistry 2010,7(3),915-921

56- Saeed Emami^a,*_{, Abbas Kebriaeezadeh}^b_,Nematollah Ahangar^c,Reza Khorasani^b, Imidazolylchromanone Oxime ethers as Potential anticonvulsant agents: Anticonvlsive evaluation in PTZ- Kindling model of epilepsy and SAR Study, Bioorganic&Medicinal Chemistry Letters xxx (2010)xxx-xxx

57- N.Amini-Shirazi,²R. Ahmadkhaniha, ^3.5S. Shadnia,¹M.H. Ghahremani,M. Abdollahi,²A. Dadgar and A.Kebriaeezadeh, Determination of VPA and its Two Important Metabolites in Iranian Overdosed Patients , International Journal of Pharmacology,2010 IssN 1811-7775; 6(6); 854-862.

58- Noushin Amini-Shirazi^1,2,Mohammad Hossein Ghahremani¹,Reza Ahmadkhaniha³,Ali Mandegary⁴,Armin Dadgar³,Mohammad Abdollahi¹,Shahin Shadnia^5,6,Hossein Pakdaman⁶,and Abbas Kebriaeezadeh¹- Influence of CYp2C9 Polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian Patients,Toxicology Mechanisms and Methods ,2010,20(8): 452-457

59- Rezaei Mokarram A., ²Kebriaee Zadeh A.,³Keshavarz M.,³Ahmadi A.,³Mohtat B., Preparation and in- Vitro evaluation of indomethacin nanoparticles, DARU Vol. 18,No.3 2010; 185-192.

60- Seyed Vahid Shetab Boushehri¹,Seyed Nasser Ostad¹,Saeed Sarkar²,Dmitry A.Kuznetsov³,Anatoly L. Buchachenko⁴,Marian A.Orlova,Bagher Minaii⁵,Abbas Kebriaeezadeh¹,and Seyed Mahdi Rezayat⁶. The C₆₀-Fullerene Porphyrin Adducts for Prevention of the Doxorubicin- Induced Acute Cardiotoxicity in Rat Myocardial Cells; Acta Medica Iranica; (2010); 48(5); 342-350.

61- Saeed Emami , Abbas Kebriaeezadeh , Nematollah Ahangar , Reza Khorasani

Imidazolylchromanone oxime ethers as potential anticonvulsant agents:

Anticonvulsive evaluation in PTZ-kindling model of epilepsy and SAR study; Bioorganic and Medicinal Chemistry Letters (2011); 21;655-659.

62. Akbar Abdollahiasl, Abbas Kebriaeezadeh, Shekoufeh Nikfar, Amir Farshchi, Golbarg Ghiasi, Mohammad Abdollahi; Patterns of antibiotic consumption in Iran during 2000-2009; International journal of antimicrobial agents;37( 2011); 489-490.

63. Kian Azami, Kaveh Tabrizian, Rohollah Hosseini, Mohammad Seyedabadi, Marjan Shariatpanahi, Farshid Noorbakhsh, Abbas Kebriaeezadeh, Seyed Nasser Ostad, Mohammad Sharifzadeh; Nicotine attenuates spatial learning deficits induced by sodium metavanadate; Neurotoxicology; 33(2012); 44-52.

64. M.Abdollahi*,M.Baradaran,M.Etebari,T.Ghanea,Gh.Karimi, A.Kebriaeezadeh,Sh.Nikfar,M.Rahgozar,M.Saberi; 2012 ANNUALREPORTOFTEHRANDRUG&POISON INFORMATIONCENTERIN1997;

Human toxicology;

65.KhosroKeshavarz,AbbasKebriaeezadeh,AmirHashemiMeshkini, ShekoufehNikfar,ImanMirian and HasanKhoonsari ; Financialperspectiveofprivatepharmaciesin3Tehran(Iran);isitalucrativebusiness?

DARUJournalofPharmaceuticalSciences2012,20:62.

66. KebriaeeA, RasdidianA, GhiasiG, SalamzadehJ, DorkooshFA; AVAILABILITY,AFFORDABILITYANDPRICEOFASTHMAMEDICINESIN TEHRAN;IRAN; VALUEINHEALTH15(2012)A277–A575.

67. Shervin Taslimia, Alireza Esteghamatia,∗, Armin Rashidib, Hosein Moin Tavakkolia,Manouchehr Nakhjavania, Abbas Kebriaee-Zadeh; Treatment with pioglitazone is associated with decreased preprandial ghrelinlevels: A randomized clinical trial ; peptides ; 40(2013);89-92.

68. ZahraGharibnaseri,AbbasKebriaeezadeh, ShekoufehNikfar1, GholamrezaZamani, andAkbarAbdollahias ; Cost-effectivenessofadding-onnewantiepileptic drugstoconventionalregimensincontrolling intractableseizuresinchildren ; DARUJournal of Pharmaceutical Sciences2012,20:17.

69. AmirHashemiMeshkini, AbbasKebriaeezadeh, RasoulDinarvand, ShekoufehNikfar, MohammadGafarHabibzadeh, and ImanVazirian; AssessmentofthevaccineindustryinIranin contextofaccessiontoWTO:asurveystudy . DARUJournal of Pharmaceutical Sciences 2012,20:19.

70. HosseinMirmiranpoura, S.ZahraBathaieb,⁎, ShahnazKhaghania, ManouchehrNakhjavanic, AbbasKebriaeezadeh ; Investigationofthemechanism(s)involvedindecreasingincreasedfibrinogen activityinhyperglycemicconditionsusingL-lysinesupplementation;

Thrombosis research; 2012;

71. AmirHashemi-Meshkini, KhosroKeshavarz, ZahraGharibnaseri, MehrnazKheirandish, Abbas Kebriaeezadeh, Shekoufeh Nikfar, Mohammad Abdollahi; Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer; Arch Med Sci; 2013;

72. Amir Hashemi-Meshkinia, Khosro Keshavarza, Shekoufeh Nikfara,b, Iman Vazirianc and Abbas Kebriaeezadeh; Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study ; Iranian Journal of Pharmaceutical Research (2013), 12 (4): 953-962.

73. Saman Zartab, S. Farshad Fatemi, Abbas Kebriaee-zadeh, Ramin Radmanesh; Fundamentals and Stock Return in Pharmaceutical Companies: a Panel Data Model of Iranian Industry ; Iranian Journal of Pharmaceutical Sciences Winter 2013: 9(1): 114-170.

74. AbbasKebriaeezadeh, NasserNassiriKoopaei, AkbarAbdollahiasl1, ShekoufehNikfar, and NafisehMohamadi; Trend analysis of the pharmaceutical market in Iran;1997–2010; policy implications for developing countries ; DARUJournal of Pharmaceutical Sciences 2013,21:52.

75. ShekoufehNikfar , AbbasKebriaeezadeh, RassoulDinarvand, MohammadAbdollahi, Mohammad-Ali Sahraian, David Henry, and Ali Akbari Sari; Cost-effectivenessofdifferentinterferonbeta productsforrelapsing-remittingandsecondary progressivemultiplesclerosis:Decisionanalysis basedonlong-termclinicaldataandswitchable treatments ; DARU Journal of Pharmaceutical Sciences2013,21:50.

76. Khosro Keshavarz1, Amir Hashemi-Meshkini, Zahra Gharibnaseri, Shekoufeh Nikfar, Abbas Kebriaeezadeh, Mohammad Abdollahi; A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience ; Arch Med Sci 2013; 9, 6: 961–967.

77 . Shahrooz Saremi, RassoulDinarvand, AbbasKebriaeezadeh, Seyed Nasser Ostad, and Fatemeh Atyabi1, ; Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies ; BioMed Research International; 2013 .

78. Hamid Irannejada, Abbas Kebriaieezadehb, Afshin Zarghi, Farhad Montazer-Sadeghb, AbbasShafiee, Amir Assadi eskandar, MohsenAmini ; Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2inhibitors ; Bioorg. Med. Chem.22(2014)865–873.

79. Mohammad Ali Rezvanfar, Abbas Kebriaeezadeh, Mostafa Moein, Shekoufeh Nikfar, Zahra Gharibnaseri, Akbar Abdollahi-Asl. Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies ; Journal of Research in Pharmacy Practice / Oct-Dec 2013 / Vol 2 / Issue 4; 162-168.

80. Amir Hashemi Meshkini , Abbas Kebriaeezadeh , Mohammad Reza Janghorban , Khosro Keshavarz 1, Shekoufeh Nikfar ; Assessment of Geographic Accessibility to Pharmacy in Qom, Iran: A Geographic Information System Analysis ; Thrita. 2014;3(1):e9648; 1-6.

81 Nasser Nassiri-Koopaei, RezaMajdzadeh, AbbasKebriaeezadeh, ArashRashidian, MojtabaTabatabai Yazdi, Saharnaz Nedjat, and Shekoufeh Nikfar. Commercializationofbiopharmaceutical knowledgeinIran;challengesandsolutions ; DARU Journal of Pharmaceutical Sciences ; 2014,22:29.

82- Ali-Akbar Golabchifar, Saeed Rezaee, Nahid Mobarghei Dinan, Abbas Kebriaeezadeh, Mohammad-Reza Rouini, Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers; Eur J Drug Metab Pharmacokinet; july 2015.

83- Hossein Mirmiranpour, Shahnaz Khaghani, S. Zahra Bathaie, Manouchehr Nakhjavani, Abbas Kebriaeezadeh, Maryam Ebadi, Siavash Gerayesh-Nejad , and Mohammad Zangooei; The Preventive Effect of L-Lysine on Lysozyme Glycation in Type 2 Diabetes; Acta Medica Iranica, Vol. 54, No. 1 (2016);24-31.

84-Jaberidoost M, Olfat L, Hosseini A^, Kebriaeezadeh A, Abdollahi M, Alaeddini M, Dinarvand R; Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods; J Pharm Policy Pract. 2015 Feb 28;8(1):, .2-10.

85- Amirreza Hosseinzadeh1, Alireza Yektadoost1, Hamidreza Hozouri2, Rassoul Dinarvand3, Abbas Kebriaeezadeh; Quality Assurance Status in Iranian Pharmaceutical Industry: A Survey: Journal of Pharmacoeconomics and Pharmaceutical Management 2014; 1(1): 14-21.

86- Mehrnaz Kheirandish, Zahra Gharibnaseri, Fatemeh Soleymani, Abbas Kebriaeezadeh; Prior authorization by the Health Insurance Organizations in Iran ; Journal of Pharmacoeconomics and Pharmaceutical Management 2015; 1(2): 59-60.

87- Zahra Gharibnasri, Mehrnaz Kheirandis, Bahram Delfan, Abbas Kebriaeezadeh; Geographical distribution of pharmacies in two provincial capitals in Iran; Journal of Pharmacoeconomics and Pharmaceutical Management 2015; 1(2): 53-55.

88- Mehrnaz Kheirandish, Arash Rashidian, Abbas Kebriaeezade, Abdol Majid Cheraghali, Fatemeh Soleymani; A review of pharmaceutical policies in response to economic crises and sanctions; Journal of Research in Pharmacy Practice / Jul-Sep 2015 / Vol 4 / Issue3.

89 - Nima Tahmasebi and Abbas Kebriaeezadeh; Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods; Iranian Journal of Pharmaceutical Research (2015), 14 (2):

90- Akbar Abdollahiasl,Abbas Kebriaeezadeh,Rassoul Dinarvand, Mohammad Abdollahi, Abdol Majid Cheraghali , Mona Jaberidoost, Sh

دکتر عباس کبریایی زاده

دکتر عباس کبریایی زاده